European Medicines Agency Issues Support for New Recombinant Pertussis Vaccine
A new pertussis vaccine, which has been designed to be used as a booster and for vaccinating pregnant women, has received “positive regulatory support” from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). Marketed under the name VacPertagen, the recombinant pertussis vaccine—formulated with genetically engineered proteins rather than inactivated whole […]